GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BGM Group Ltd (NAS:BGM) » Definitions » Net Income From Continuing Operations

BGM (BGM Group) Net Income From Continuing Operations : $-1.52 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BGM Group Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. BGM Group's net income from continuing operations for the six months ended in Sep. 2024 was $-1.85 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.52 Mil.

BGM Group Net Income From Continuing Operations Historical Data

The historical data trend for BGM Group's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGM Group Net Income From Continuing Operations Chart

BGM Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Net Income From Continuing Operations
Get a 7-Day Free Trial 4.94 3.11 1.37 -8.12 -1.52

BGM Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.12 0.44 -8.56 0.33 -1.85

BGM Group Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGM Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BGM Group Ltd (NAS:BGM) » Definitions » Net Income From Continuing Operations
Comparable Companies
ALVO AMRX BCRX KNSA SUPN PRGO NDOI ANIP PCRX DVAX ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
Website
https://www.bgmgroupltd.com
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.